METABOLIC PROTECTORS IN COMPLEX THERAPY OF ORGANO-PHOSPHATE INTOXICATIONS
https://doi.org/10.25016/2541-7487-2013-0-1-84-89
Abstract
The purpose of investigation was to study defensive mechanisms of metaprot and ethomerzol (25 and 50 mg/kg) in a rat model of acute carbophos intoxication (256.0 ± 8.7) mg/kg. Both compounds recovered physical load tolerance, normalized the activity of aspartate and alanine transaminases, reduced bilirubine, creatinine and urea nitrogen levels. Effects on lipid peroxidation were reported as decreased malonic dialdehyde concentration and increased levels of reduced glutathione, as well as elimination of signs of endogenic intoxication. Antihypoxic, antioxidant, actoprotective, energotropic and reparative effects of metaprot and ethomerzol were proved.
About the Authors
V. V. VorobievaRussian Federation
I. V. Zarubina
Russian Federation
P. D Shabanov
Russian Federation
References
1. Aruin L.I. Novaya mezhdunarodnaya klassifikatsiya displazii slizistoi obolochki zheludka [The new international classification of dysplasia of the gastric mucosa]. Rossiiskii zhurnal gastroenterologii, gepatologii i koloproktologii [The Russian Journal of Gastroenterology, Hepatology and Coloproctology]. 2002. N 12. Pp. 15–17. (In Russ.)
2. Khaitov R.M., Ignat'eva G.A., Sidorovich I.G. Immunologiya [Immunology]. Moskva. 2000. 458 p. (In Russ.)
3. Tsimmerman Ya.S. Gastroenterologiya [Gastroenterology]. Moskva. 2012. 800 p.
4. Yarilin A.A. Immunologiya [Immunology]. Moskva. 2010. 749 p. (In Russ.)
5. Blaser M.J. Helikobacter pylory and gastric disease. BMJ. 1998. Vol. 316, N 7143. Pp. 1507–1510.
6. Guarner J., Baetlett J., Seitz R. [et al.]. Cell proliferation and inflammation on biopsy samples with multifocal atrophic gastritis before and 2 year after Helicobacter pylori eradication. Arch. Pathol. Lab Med. 2005. Vol. 129, N 11. Pp. 1451–1456.
7. Ormerod M.G. [et al.]. Consensus report of the task force on standardization of DNA flow cytometry in clinical pathology. Anal. Cell Pathol. 1998. Vol. 17. Pp. 103–110.
8. Correa P. The gastric precancerous process. Cancer Surv. 1983. Vol. 2. Pp. 437–450.
9. Correa P. Human gastric cancerogenesis: a multistep and multifactorial process. Cancer rev. 1992. N 52. Pp. 6735–6740.
10. Lu A.P., Zhang S.S/, Zha O.L. [et al.]. Correlatio between CD4,CD8 cell infiltration in gastric mucosa, H. pylori infection and symptoms in patients with chronic gastritis. Wold J. Gastroenterol. 2005. Vol. 28. Pp. 2486–2490.
11. Shankey T.V., Rabinovitch P.S., Bagwell B. [et al.]. Guidelines for implementation of clinical DNA cytometry. Cytometry. 1993. Vol. 14. Pp. 472–477.
12. Smythies L.E., Waites K.B., Lindsey J.R., Harris P.R. Helicobacter pylori–induced mucosal inflammation is TH-1 mediated and exacerbated in IL-4, but not IFN-gamma, genedeficient mice. J. Immunol. 2000. Vоl. 165. Pp. 1022–1029.
13. Brajsa K., Ferencic Z., Katicic M. [et al]. Influence of H.pylori infection and eradication on p53, cerbB-2 and Ki-67 in gastric mucosa. Hepatogastroenterology. 2006 Vol. 53. Pp. 968– 972.
14. Kovama S. Apoptotic depletion of infiltrating mucosal lymphocytes associated with Fas ligand expression by H. pylori-infected gastric mucosal epithelium human glandular stomach as a site of immune privilege. Dig. Dis. Sci. 2000. Vol. 45. Pp. 773–780.
15. Nagayo T. Precursors of human gastric cancer: their frequencies and histological characteristics: Pathophysiol. Carcinogenesis Dig. Org. Proc. 7th Int. Symp. Princess Takamatsu. Cancer Res. Fund. 1977. Рp. 151–160.
16. Niimi C., Ohmiya N., Niwa Y. [et al.]. Use fullness of p53 and Ki-67 immunohistochemical analysis for preoperative diagnosis of extremely well-differentiated gastric adenocarcinoma. Am. J. Clin. Pathol. 2002. Vol. 118. Pp. 683–692.
Review
For citations:
Vorobieva V.V., Zarubina I.V., Shabanov P.D. METABOLIC PROTECTORS IN COMPLEX THERAPY OF ORGANO-PHOSPHATE INTOXICATIONS. Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations. 2013;(1):66-73. (In Russ.) https://doi.org/10.25016/2541-7487-2013-0-1-84-89